Caliway Biopharmaceuticals Co., Ltd. announced a oversubscribed private placement that it has issued 8,000,000 new shares at a price of $12.5 per share for the gross proceeds of $100 million on December 16, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
681 TWD | +0.74% |
|
-3.95% | +256.08% |
1st Jan change | Capi. | |
---|---|---|
+256.08% | 2.92B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- 6919 Stock
- News Caliway Biopharmaceuticals Co., Ltd.
- Caliway Biopharmaceuticals Co., Ltd. announced that it has received $100 million in funding